# Hans‐Peter Brunner‐La Rocca

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/hans-peter-brunner-la-rocca/

## Facts

| Field | Value |
| --- | --- |
| Citations | 32,161 |
| Field | Heart Failure Treatment and Management |
| h-index | 76 |
| i10-index | 270 |
| Last Known Institution | Maastricht University Medical Centre |
| OpenAlex ID | https://openalex.org/A5057864298 |
| ORCID iD | https://orcid.org/0000-0002-4356-8566 |
| Works | 507 |

## Researcher papers

- [Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure](https://scholariq.org/papers/cardiovascular-and-renal-outcomes-with-empagliflozin-in-heart-failure/)
- [Empagliflozin in Heart Failure with a Preserved Ejection Fraction](https://scholariq.org/papers/empagliflozin-in-heart-failure-with-a-preserved-ejection-fraction/)
- [Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial](https://scholariq.org/papers/mavacamten-for-treatment-of-symptomatic-obstructive-hypertrophic-cardiomyopathy/)
- [The Use of Diuretics in Heart Failure with Congestion — A Position Statement from the Heart Failure Association of the European Society of Cardiology](https://scholariq.org/papers/the-use-of-diuretics-in-heart-failure-with-congestion-a-position-statement-from/)
- [Organ Dysfunction, Injury and Failure in Acute Heart Failure: From Pathophysiology to Diagnosis and Management. A Review on Behalf of the Acute Heart Failure Committee of the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)](https://scholariq.org/papers/organ-dysfunction-injury-and-failure-in-acute-heart-failure-from-pathophysiology/)
- [Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real-world setting: randomised Basel Stent Kosten Effektivitäts Trial (BASKET)](https://scholariq.org/papers/incremental-cost-effectiveness-of-drug-eluting-stents-compared-with-a-third/)
- [Both Tadalafil and Dexamethasone May Reduce the Incidence of High-Altitude Pulmonary Edema](https://scholariq.org/papers/both-tadalafil-and-dexamethasone-may-reduce-the-incidence-of-high-altitude/)
- [Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure](https://scholariq.org/papers/prognostic-value-of-high-sensitivity-troponin-t-in-chronic-heart-failure/)
- [Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure](https://scholariq.org/papers/meta-analysis-of-soluble-suppression-of-tumorigenicity-2-and-prognosis-in-acute/)
- [The effect of spironolactone on cardiovascular function and markers of fibrosis in people at increased risk of developing heart failure: the heart ‘OMics’ in AGEing (HOMAGE) randomized clinical trial](https://scholariq.org/papers/the-effect-of-spironolactone-on-cardiovascular-function-and-markers-of-fibrosis/)

## Researcher topics

- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Cardiovascular Function and Risk Factors](https://scholariq.org/topics/cardiovascular-function-and-risk-factors/)
- [Cardiac pacing and defibrillation studies](https://scholariq.org/topics/cardiac-pacing-and-defibrillation-studies/)
- [Cardiovascular and exercise physiology](https://scholariq.org/topics/cardiovascular-and-exercise-physiology/)
- [Acute Myocardial Infarction Research](https://scholariq.org/topics/acute-myocardial-infarction-research/)

## Researcher university

- [Maastricht University Medical Centre](https://scholariq.org/institutions/maastricht-university-medical-centre/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.